Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 65309301000001118 | Exemestane 25mg tablets 28 tablet (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 65309401000001114 | Exemestane 25mg tablets 28 tablet | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Exemestane 25mg tablets 28 tablet | Is a | Virtual medicinal product pack | false | Inferred relationship | Existential restriction modifier | ||
| Exemestane 25mg tablets 28 tablet | Has VMP | Product containing precisely exemestane 25 milligram/1 each conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Exemestane 25mg tablets 28 tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Exemestane 25mg tablets 28 tablet | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Exemestane 25mg tablets 28 tablet | Has specific active ingredient | Exemestane | false | Inferred relationship | Existential restriction modifier | ||
| Exemestane 25mg tablets 28 tablet | Has dispensed dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Exemestane 25mg tablets (Beacon Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets | Is a | False | Exemestane 25mg tablets 28 tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR